Yahoo
HKSE - Delayed Quote HKD

Guangzhou Innogen Pharmaceutical Group Co., Ltd (2591.HK)

3.400 +0.130 (+3.98%)
At close: October 30 at 4:08:06 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
Total Revenue
153,281
131,509
0
0
Cost of Revenue
30,042
14,452
0
0
Gross Profit
123,239
117,057
0
0
Operating Expense
463,386
459,824
189,357
746,840
Operating Income
-340,147
-342,767
-189,357
-746,840
Net Non Operating Interest Income Expense
10,091
5,752
2,949
1,873
Pretax Income
-334,353
-341,363
-174,690
-733,376
Tax Provision
0
0
0
0
Net Income Common Stockholders
-334,353
-341,363
-174,690
-733,376
Diluted NI Available to Com Stockholders
-334,353
-341,363
-174,690
-733,376
Basic EPS
-0.73
-0.79
-0.38
-1.61
Diluted EPS
-0.73
-0.79
-0.38
-1.61
Basic Average Shares
456,819.349
434,084
456,819.349
456,819.349
Diluted Average Shares
456,819.349
434,084
456,819.349
456,819.349
Rent Expense Supplemental
--
3,007
3,336
1,509
Total Expenses
493,428
474,276
189,357
746,840
Net Income from Continuing & Discontinued Operation
-334,353
-341,363
-174,690
-733,376
Normalized Income
-340,344
-347,343
-185,551
-744,217
Interest Income
13,953
7,469
3,822
4,191
Interest Expense
3,862
1,717
873
2,318
Net Interest Income
10,091
5,752
2,949
1,873
EBIT
-330,491
-339,646
-173,817
-731,058
EBITDA
-317,397
-329,668
-156,894
-711,422
Reconciled Cost of Revenue
30,042
14,452
0
0
Reconciled Depreciation
13,094
9,978
16,923
19,636
Net Income from Continuing Operation Net Minority Interest
-334,353
-341,363
-174,690
-733,376
Total Unusual Items Excluding Goodwill
5,991
5,980
10,861
10,841
Total Unusual Items
5,991
5,980
10,861
10,841
Normalized EBITDA
-323,388
-335,648
-167,755
-722,263
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2023 - 8/15/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: